Evaluating the Mechanism of Cell Death in Melanoma Induced by the Cannabis Extract PHEC-66
Cells · 31.01.2024 · 13 (3) · 268
DOI: 10.3390/cells13030268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 31.01.2024. Verfasst von Ava Bachari und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia. Hauptthemen laut MEDLINE: Melanoma, Cannabis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MGC Pharmaceuticals Ltd, MGC Pharmaceuticals Ltd., Australia.
Abstract (Originalsprache)
Research suggests the potential of using cannabinoid-derived compounds to function as anticancer agents against melanoma cells. Our recent study highlighted the remarkable in vitro anticancer effects of PHEC-66, an extract from Cannabis sativa, on the MM418-C1, MM329, and MM96L melanoma cell lines. However, the complete molecular mechanism behind this action remains to be elucidated. This study aims to unravel how PHEC-66 brings about its antiproliferative impact on these cell lines, utilising diverse techniques such as real-time polymerase chain reaction (qPCR), assays to assess the inhibition of CB1 and CB2 receptors, measurement of reactive oxygen species (ROS), apoptosis assays, and fluorescence-activated cell sorting (FACS) for apoptosis and cell cycle analysis. The outcomes obtained from this study suggest that PHEC-66 triggers apoptosis in these melanoma cell lines by increasing the expression of pro-apoptotic markers (BAX mRNA) while concurrently reducing the expression of anti-apoptotic markers (Bcl-2 mRNA). Additionally, PHEC-66 induces DNA fragmentation, halting cell progression at the G1 cell cycle checkpoint and substantially elevating intracellular ROS levels. These findings imply that PHEC-66 might have potential as an adjuvant therapy in the treatment of malignant melanoma. However, it is essential to conduct further preclinical investigations to delve deeper into its potential and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia.
- School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia.
- Faculty of Health, Charles Darwin University, Casuarina, NT 0810, Australia.
- MGC Pharmaceuticals Limited, West Perth, WA 6005, Australia.
- The UWA Institute of Agriculture, The University of Western Australia, Perth, WA 6009, Australia.
ORCID-Profile: Nazim Nassar, Srinivasareddy Telukutla, Terrence J Piva, Nitin Mantri
Förderung
- MGC Pharmaceuticals Ltd
- MGC Pharmaceuticals Ltd., Australia
Zitieren
APA
Bachari, A., Nassar, N., Telukutla, S., Zomer, R., Piva, T. J., & Mantri, N. (2024). Evaluating the Mechanism of Cell Death in Melanoma Induced by the Cannabis Extract PHEC-66. Cells, 13(3), 268. https://doi.org/10.3390/cells13030268
Vancouver
Bachari A, Nassar N, Telukutla S, Zomer R, Piva TJ, Mantri N. Evaluating the Mechanism of Cell Death in Melanoma Induced by the Cannabis Extract PHEC-66. Cells. 2024;13(3):268. doi:10.3390/cells13030268
BibTeX
@article{Bachari2024,
author = {Bachari, Ava and Nassar, Nazim and Telukutla, Srinivasareddy and Zomer, Roby and Piva, Terrence J and Mantri, Nitin},
title = {Evaluating the Mechanism of Cell Death in Melanoma Induced by the Cannabis Extract PHEC-66},
journal = {Cells},
year = {2024},
volume = {13},
number = {3},
pages = {268},
doi = {10.3390/cells13030268}
}
EUVIMED